chr20-31389132-G-A
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_153289.4(DEFB119):c.61+1291C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000638 in 1,614,172 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_153289.4 intron
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DEFB119 | ENST00000376315.2 | c.160C>T | p.Arg54Cys | missense_variant | Exon 2 of 2 | 1 | ENSP00000365492.2 | |||
DEFB119 | ENST00000376321.4 | c.61+1291C>T | intron_variant | Intron 1 of 1 | 1 | NM_153289.4 | ENSP00000365499.3 | |||
DEFB119 | ENST00000339144.3 | c.61+1291C>T | intron_variant | Intron 1 of 2 | 1 | ENSP00000345768.3 | ||||
DEFB119 | ENST00000492344.1 | n.148-773C>T | intron_variant | Intron 1 of 3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000302 AC: 46AN: 152168Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000835 AC: 21AN: 251490 AF XY: 0.0000515 show subpopulations
GnomAD4 exome AF: 0.0000390 AC: 57AN: 1461886Hom.: 0 Cov.: 35 AF XY: 0.0000358 AC XY: 26AN XY: 727242 show subpopulations
GnomAD4 genome AF: 0.000302 AC: 46AN: 152286Hom.: 0 Cov.: 31 AF XY: 0.000322 AC XY: 24AN XY: 74454 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.160C>T (p.R54C) alteration is located in exon 2 (coding exon 2) of the DEFB119 gene. This alteration results from a C to T substitution at nucleotide position 160, causing the arginine (R) at amino acid position 54 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at